INS and Insulin resistance: It is noteworthy that no differences in whole-body insulin-stimulated glucose disposal or in glycemic control and abdominal adiposity were observed between T2DM individuals with or without MetS indicating that worsening of cardiac insulin resistance is a feature that is exacerbated by the presence of metabolic syndrome.